How Should a Health System Choose Clinical Documentation AI in 2026?

Choose on five criteria, roughly in this order: BAA readiness, independent security attestation (SOC 2), EHR write-back architecture, human-in-the-loop governance, and only then note quality. Most selection processes run this list backwards. They start with demo-room note quality — which every serious vendor can now show — and discover the compliance and governance gaps in contracting, when switching costs are already high.

This guide gives clinical and IT leaders a working evaluation sequence, the vendor questions that separate marketing from architecture, and a checklist to take into procurement.

Why the BAA comes first

Without a signed Business Associate Agreement, nothing else matters: documentation AI processes PHI by definition, and HIPAA requires a BAA with any vendor acting as a business associate. The practical question is not whether a vendor will sign one, but what theirs covers — which subprocessors are in scope, whether PHI reaches the model provider, and what happens to audio and transcripts after the note is signed.

Ask three questions in the first meeting. Who are the subprocessors, and does the BAA chain cover them? Is PHI used for model training, and is that a contractual commitment or a settings default? What are the retention and deletion terms for recordings, transcripts, and drafts? (AIdMD's answers: a BAA is available; the platform runs on Microsoft Azure using HIPAA-eligible services; PHI is not used for model training.)

What to expect on security attestation

Expect an independent SOC 2 attestation, and actually read it: request the current report under NDA and have your security team review its scope, exceptions, and complementary controls. A report you have read beats a badge you have seen. Beyond the report, confirm the unglamorous basics — encryption in transit and at rest, role-based access control, single sign-on, and audit-log retention that satisfies your policy. HIPAA's six-year documentation expectations make audit-log retention a specific question worth asking, not assuming.

AIdMD's posture on these basics is public: the platform is SOC 2 Type II certified and HIPAA-compliant, encrypts data in transit and at rest, enforces role-based access control, retains audit logs for six years, and does not use PHI to train models. Whatever the vendor, insist on the same specifics in writing.

What EHR write-back architecture reveals

Write-back is where documentation AI becomes real: a tool that drafts into a side window is a text generator, while a tool that writes into the chart is clinical infrastructure and must be evaluated as such. Ask precisely how content enters the record — through a standards-based integration (SMART on FHIR, FHIR APIs), a vendor-specific module, or copy-and-paste by the clinician.

The architecture determines three things buyers care about: deployment effort, EHR coverage, and failure modes. Standards-based layers deploy without custom interface projects and travel across EHRs — AIdMD Insights connects to Epic, Oracle Health, athenahealth, eClinicalWorks, Practice Fusion, and gGastro this way. Deep vendor-specific embeds can be excellent where they exist, but coverage is bounded by the modules the vendor has built. Match the architecture to the EHRs you actually run, including the ambulatory and specialty systems your groups use.

What human-in-the-loop governance requires

It requires that a named clinician approves every clinical artifact before it enters the record — notes, orders, referrals, prescriptions — with an audit trail of who approved what, and no autonomous path around it. In evaluation, make vendors demonstrate the mechanism, not recite the principle: What exactly can the system write without a signature? Can approval be delegated or batched into meaninglessness? Is there an override log?

This is the criterion where category differences show. Conversation-first tools mostly draft notes, so their governance surface is narrow. Chart-aware platforms draft more — orders, referrals, coding — so the approval gate carries more weight. AIdMD enforces approval-before-write on every clinical action as an architectural rule. Whatever platform you choose, insist the equivalent rule is enforced in software rather than promised in training.

Judge note quality last — on your own encounters

Judge note quality with your own clinicians, your own specialties, and your own messy encounters, after a vendor has cleared compliance and governance. Run a structured pilot: the same clinicians, defined specialties, and a rubric covering accuracy, completeness, coding usefulness, and edit burden. Test the chart side too — ask what the system knew about the patient before the visit, because documentation grounded in the record catches what conversation-only capture misses.

A checklist for procurement

Contracting: BAA scope and subprocessors; a written PHI-training commitment; retention, deletion, and data-return terms. Security: the current SOC 2 report and its scope; encryption; role-based access and single sign-on; audit-log retention. Architecture: named EHR integrations and the standard behind each; what writes back and how; a deployment timeline in weeks with references. Governance: a live demonstration of approval-before-write and override logging. Commercials: per-provider price (published or quoted), seat definitions, and first-year all-in cost.

For a documentation workflow that drafts from both the encounter and the chart and keeps a clinician's signature in front of every note, look at AIdMD Insights — schedule a demo to run it against your own EHR.